Psoriasis and metabolic syndrome: Is peroxisome proliferator-activated receptor-γ part of the missing link?

Abstract

Reduced PPARγ could be added to the factors responsible for translating the metabolic state among psoriatic patients. PPARγ agonists can present an adjuvant therapeutic tool in treatment of psoriatics with MS.